title: Worsening bradycardia following antithymocyte globulin treatment of severe aplastic anemia.
abstract: Immunosuppressive regimens, which include antithymocyte globulin (ATG), are widely used for the treatment of severe aplastic anemia (SAA). However, bradycardia has been reported only as a rare side effect of ATG therapy in the manufacturer's product information and, in rare cases, in the adult literature. We present an adolescent with SAA and preexisting bradycardia who underwent immunosuppression therapy with ATG, methylprednisolone, and tacrolimus and developed profound sinus bradycardia with successive doses of ATG.
authors.forename: Justin
authors.initials: J
authors.lastname: Godown
authors.forename: Allison M
authors.initials: AM
authors.lastname: Deal
authors.forename: Kathy
authors.initials: K
authors.lastname: Riley
authors.forename: Frederique
authors.initials: F
authors.lastname: Bailliard
authors.forename: Julie
authors.initials: J
authors.lastname: Blatt